Skip to main content

Table 1 Main patient characteristics

From: Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients

Characteristic N o. of patients %
Patients evaluable 41 100
Age, years   
Median 60 /
Range 32-75  
ECOG PS   
0 13 32
1 21 51
2 7 17
Tumor histology/citology   
Serous adenocarcinoma 10 24.5
Adenocarcinoma 7 17
Papillary serous 6 15
Clear cell adenocarcinoma 2 5
Endometrioid 3 7
Mucinous adenocarcinoma 3 7
Poorly differentiated 10 24.5
Stage at diagnosis   
I,II 2 5
III (A, B, C) 33 (10, 12, 11) 80
IV 6 15
N of prior chemotherapy regimens   
1 3 7
2 12 29
≥3 26 64
N of prior platinum-based regimens   
1 23 56
2 9 22
3 9 22
  1. Abbreviations: ECOG PS, Eastern Cooperative Oncoloy Group Performance Status.